Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2023-12-15 Director's Dealing
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
LIFE: Notofication of trade by party closely related to primary insider
Director's Dealing Classification · 1% confidence The document explicitly states it is a "Notofication of trade by party closely related to primary insider" and details a transaction involving shares sold by Islay Ventures GmbH, a company controlled by Lifecare CSO Prof. Dr. Dr. Med Andreas Pfützner. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The filing type code for this is DIRS. The document length is short, but the content is the primary disclosure itself, not an announcement of a separate report.
2023-12-15 English
LIFE: Final purchase order for automated production components - micro-fluidic handling and dispensing devices
Regulatory Filings Classification · 1% confidence The document is a short press release dated December 13th, 2023, announcing that Lifecare AS has placed a final purchase order for automated production equipment (BioScaffolder and Nano-Plotter). It references previous market communications and a semi-annual report, but the content itself is an update on operational progress and capital expenditure related to production setup, not a full financial report (like 10-K or IR), a formal dividend notice, or a management change announcement. Since it details a significant investment/financing activity related to scaling up operations, it best fits the 'Capital/Financing Update' category. Given its nature as a specific operational update disclosed via stock exchange notification, it is not a general 'Regulatory Filing' (RNS) but a specific business event announcement.
2023-12-13 English
LIFE: Final purchase order for automated production components - micro-fluidic handling and dispensing devices
Share Issue/Capital Change Classification · 1% confidence The document is a short press release dated December 13th, 2023, announcing that Lifecare AS has placed a final purchase order for production equipment necessary for automated manufacturing. It references previous communications, including a semi-annual report, but the document itself is an announcement about a business/operational milestone (equipment purchase) rather than a full financial report (like 10-K or IR) or a formal regulatory filing like a Director's Dealing or Major Shareholding Notification. Since it is a specific operational update that doesn't fit the primary financial/governance codes (10-K, IR, DIV, DIRS, etc.), and it is not an announcement of a report publication (RPA), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a catch-all for significant, non-standard announcements submitted under securities regulations (as indicated by the final sentence referencing 'MAR Article 19 no. 3').
2023-12-13 English
LIFE: Purchase order on scanning electron microscope from Zeiss
Capital/Financing Update Classification · 1% confidence The document is a short press release dated November 28th, 2023, announcing that Lifecare AS has placed a purchase order for a Scanning Electron Microscope (SEM) from Zeiss. It discusses operational milestones related to setting up an automated production line and achieving pilot production goals. The text is an announcement of a specific business event (a major purchase supporting future production) rather than a comprehensive financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV). It does not fit the definitions for AGM-R, 10-K, AR, CT, CAP, DVA, DLST, DIRS, ER, SR, FS, CGR, IRAT, IP, LTR, TAR, MRQ, MDA, NAV, PSI, DEF 14A, RNS, SHA, or POS. Since it is a specific, material business update that doesn't fit the other specialized categories, it is best classified as a general Regulatory Filing (RNS), as it is a mandatory disclosure under securities regulations (referenced at the end: 'Securities Trading Act § 5-12 and MAR Article 19 no. 3'). Given the short length and nature as a specific operational update, RNS is the most appropriate fallback.
2023-11-28 English
LIFE: Purchase order on scanning electron microscope from Zeiss
Regulatory Filings Classification · 1% confidence The document announces a specific operational event: Lifecare AS placing a purchase order for a Scanning Electron Microscope (SEM) from Carl Zeiss AG, which is described as a key component for setting up an automated production line for their Continuous Glucose Monitor (CGM) sensors. This is a material operational update concerning future production capabilities and milestones previously communicated to investors. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a formal proxy/governance document. It is a specific, material announcement that relates to capital expenditure and operational progress. Given the options, this type of specific, material operational news that doesn't fit neatly into financial reporting or governance categories is best classified as a general Regulatory Filing (RNS), as it is submitted pursuant to securities trading acts (§ 5-12 and MAR Article 19 no. 3) but does not match the more specific categories like CAP (financing/fundraising) or TAR (M&A). It is a disclosure of a significant operational step.
2023-11-28 English
LIFE: Successful ISO 13485 audit
Environmental & Social Information Classification · 1% confidence The document is a press release dated November 20th, 2023, announcing that Lifecare Laboratory successfully passed an ISO 13485 audit, which is a quality management system standard specific to medical devices. It discusses progress towards regulatory compliance (CE mark) and future product launch milestones. This type of announcement, detailing operational progress, quality system achievements, and regulatory steps, does not fit neatly into the specific financial reporting categories (10-K, IR, ER, MRQ) or specific corporate actions (DIV, CAP, DIRS). It is a general operational update related to quality and regulatory affairs. Since it is not a formal financial report, a management discussion, or a specific corporate event like a dividend or merger, it falls best under the general 'Regulatory Filings' (RNS) category as a significant operational disclosure, or potentially 'Audit Report / Information' (AR) if the focus was strictly on the audit results, but AR is defined as standalone audit reports or stress tests, not an announcement about passing an external certification audit. Given the context of a press release announcing a milestone related to quality systems necessary for future regulatory approval, RNS is the most appropriate general regulatory disclosure category.
2023-11-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.